Kirby McInerney LLP is investigating potential claims against the Board of Directors of DaVita HealthCare Partners Inc. (“DaVita” or the “Company”) (NYSE:DVA) concerning a final settlement agreement in the pending 2010 and 2011 U.S. Attorney Physician Relationship Investigations of the Company.
On October 22, 2014, the U.S. Department of Justice (“DOJ”) announced that it entered into a Settlement Agreement with DaVita regarding the Company’s violations of certain provisions of the False Claims Act. The DOJ and other federal agencies alleged that the Company engaged in improperly structured joint ventures with certain physician partners. Under the terms of the Settlement Agreement, the Company will pay $350 million to the United States plus a civil forfeiture of $39 million. The Company has also agreed in principle to settle certain state Medicaid claims for $11.5 million.
In addition, the DOJ announced that DaVita has entered into a five-year Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services, which will subject the Company to expanded compliance-related requirements including the retention of an independent monitor to oversee certain future joint ventures, a repayment to the government, and a provision requiring executive certification of quarterly and annual compliance reports.
If you are a DaVita stockholder and wish to obtain additional information, please contact Vishan Patel by email at vpatel@kmllp.com, or telephone at (212) 699-1147, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.
Contacts:
Vishan Patel, 212-699-1147
vpatel@kmllp.com
or
Toll
Free: 888-529-4787
